Key Highlights
- Shares are trading down about 24.48% today, a steep single-session decline.
- President and CEO Everett Cunningham stepped down effective immediately.
- Cunningham is leaving to join GeneDx as its incoming CEO.
- Chief Commercial Officer Jim Gute was named Interim President and CEO.
- The board reaffirmed the company's full-year 2026 financial outlook.
Quanterix (NASDAQ:QTRX) shares are plunging today after the company announced that President and CEO Everett Cunningham has stepped down effective immediately, departing to accept the CEO role at GeneDx (NASDAQ:WGS). Quanterix is a global leader in precision biomarker science, developing ultra-sensitive biomarker detection platforms used in disease research, diagnostics, and drug development.
Chief Commercial Officer Named Interim CEO
The board appointed Jim Gute, the company's Chief Commercial Officer, to the additional role of Interim President and CEO while it conducts a search for a permanent successor. The board has engaged an executive search firm and will consider both internal and external candidates, with Cunningham remaining available to assist with an orderly transition through December 11.
Board Highlights Recent Commercial and Diagnostics Progress
The board chairman thanked Cunningham for his contributions and pointed to significant talent additions made during 2026 that have reinvigorated the company's commercial organization and advanced its Alzheimer's diagnostics business. Gute was appointed Chief Commercial Officer in August 2026 after prior commercial Leadership roles at Exact Sciences and GE Healthcare.
Company Reaffirms Its Full-Year Financial Outlook
Despite the abrupt leadership change, the company reaffirmed its 2026 financial outlook as previously provided on November 9, suggesting the departure is not expected to materially affect near-term financial expectations.
What Comes Next for Quanterix's Leadership Search
With Cunningham's transition period running through December 11, investors are likely to focus on the pace of the board's search for a permanent CEO and whether interim leadership under Gute can maintain commercial momentum in the meantime.






Please wait processing your request...